These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 16312325)

  • 21. Efficacy of the bovine antimicrobial peptide indolicidin combined with piperacillin/tazobactam in experimental rat models of polymicrobial peritonitis.
    Ghiselli R; Giacometti A; Cirioni O; Mocchegiani F; Orlando F; Silvestri C; Di Matteo F; Abbruzzetti A; Scalise G; Saba V
    Crit Care Med; 2008 Jan; 36(1):240-5. PubMed ID: 18090372
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Differences in the changes in resistance patterns to third- and fourth-generation cephalosporins and piperacillin/tazobactam among Klebsiella pneumoniae and Escherichia coli clinical isolates following a restriction policy in a Greek tertiary care hospital.
    Petrikkos G; Markogiannakis A; Papaparaskevas J; Daikos GL; Stefanakos G; Zissis NP; Avlamis A
    Int J Antimicrob Agents; 2007 Jan; 29(1):34-8. PubMed ID: 17189092
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [A combined dosage form of piperacillin and tazobactam--tazocin].
    Iakovlev SV
    Antibiot Khimioter; 1997; 42(2):5-16. PubMed ID: 9124994
    [No Abstract]   [Full Text] [Related]  

  • 24. [Pharmacological properties and clinical efficacies of tazobactam/piperacillin (Zosyn 2.25, Zosyn 4.5), an injectable antibiotic combined with beta-lactamase inhibitor].
    Uji T; Hashimoto Y
    Nihon Yakurigaku Zasshi; 2009 Jun; 133(6):351-8. PubMed ID: 19521033
    [No Abstract]   [Full Text] [Related]  

  • 25. Expanded studies of piperacillin/tazobactam formulations: variations among branded product lots and assessment of 46 generic lots.
    Moet GJ; Watters AA; Sader HS; Jones RN
    Diagn Microbiol Infect Dis; 2009 Nov; 65(3):319-22. PubMed ID: 19822271
    [TBL] [Abstract][Full Text] [Related]  

  • 26. In vitro study of the antibacterial activity of cefotetan compared with piperacillin and ceftriaxone against bacterial strains isolated from pathological material of hospital patients.
    Gatti M; Varoli O; Piscolla F
    J Chemother; 1989 Jul; 1(4 Suppl):103-4. PubMed ID: 16312324
    [No Abstract]   [Full Text] [Related]  

  • 27. Pharmacokinetic/pharmacodynamic modeling to predict in vivo effectiveness of various dosing regimens of piperacillin/tazobactam and piperacillin monotherapy against gram-negative pulmonary isolates from patients managed in intensive care units in 2002.
    Frei CR; Burgess DS
    Clin Ther; 2008 Dec; 30(12):2335-41. PubMed ID: 19167592
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clinical implications of revised piperacillin-tazobactam breakpoints in CLSI M-100 S32.
    Dash D; Rai S
    Indian J Med Microbiol; 2023; 42():108-109. PubMed ID: 36241530
    [No Abstract]   [Full Text] [Related]  

  • 29. Microbiological and clinical characteristics of diabetic foot infections in northern India.
    Tiwari S; Pratyush DD; Dwivedi A; Gupta SK; Rai M; Singh SK
    J Infect Dev Ctries; 2012 Apr; 6(4):329-32. PubMed ID: 22505442
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Enhanced activity of beta-lactam antibiotics with amdinocillin in vitro and and in vivo.
    Cleeland R; Squires E
    Am J Med; 1983 Aug; 75(2A):21-9. PubMed ID: 6311002
    [TBL] [Abstract][Full Text] [Related]  

  • 31. In vitro activities of various piperacillin and sulbactam combinations against bacterial pathogens isolated from Intensive Care Units in Taiwan: SMART 2004 programme data.
    Hung MN; Hsueh PR; Chang HT; Lee WS; Chou MY; Chen IS; Wang JH; Lin CF; Shyr JM; Ko WC; Wu JJ; Liu YC; Huang WK; Teng LJ; Liu CY; Luh KT
    Int J Antimicrob Agents; 2007 Feb; 29(2):145-52. PubMed ID: 16815690
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Treating diabetic foot infections with sequential intravenous to oral moxifloxacin compared with piperacillin-tazobactam/amoxicillin-clavulanate.
    Lipsky BA; Giordano P; Choudhri S; Song J
    J Antimicrob Chemother; 2007 Aug; 60(2):370-6. PubMed ID: 17553812
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A new powerful antibacterial synergistic combination of trimethoprim and trimeprazine.
    Guha Thakurta A; Mandal SK; Ganguly K; Dastidar SG; Chakrabarty AN
    Acta Microbiol Immunol Hung; 2000; 47(1):21-8. PubMed ID: 10735187
    [TBL] [Abstract][Full Text] [Related]  

  • 34. In vitro and in vivo evaluation of the penem FCE 22101 and its orally absorbed ester FCE 22891.
    Bruna CD; Jabes D; Sebben G; Sanfilippo A
    G Ital Chemioter; 1983; 30(2-3):125-30. PubMed ID: 6329870
    [No Abstract]   [Full Text] [Related]  

  • 35. Experience with the use of piperacillin-tazobactam in pediatric non-renal solid organ transplantation.
    Wiesmayr S; Stelzmueller I; Mark W; Muehlmann G; Tabarelli W; Tabarelli D; Laesser R; Antretter H; Ladurner R; Zimmerhackl LB; Margreiter R; Guggenbichler JP; Bonatti H
    Pediatr Transplant; 2007 Feb; 11(1):38-48. PubMed ID: 17239122
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comment on: Pharmacodynamic evaluation of intermittent versus extended and continuous infusions of piperacillin/tazobactam in a hollow-fibre infection model against Klebsiella pneumoniae.
    Giry M; Sarfati S; Pestel-Caron M; Wils J; Lamoureux F; Alexandre K
    J Antimicrob Chemother; 2022 Sep; 77(10):2892-2894. PubMed ID: 35538913
    [No Abstract]   [Full Text] [Related]  

  • 37. Antimicrobial susceptibility of well-characterised multiresistant CTX-M-producing Escherichia coli: failure of automated systems to detect resistance to piperacillin/tazobactam.
    Pitout JD; Le P; Church DL; Gregson DB; Laupland KB
    Int J Antimicrob Agents; 2008 Oct; 32(4):333-8. PubMed ID: 18701262
    [TBL] [Abstract][Full Text] [Related]  

  • 38. YTR-830H: its origin, the present and the future.
    Yamabe S
    J Chemother; 1989 Jul; 1(4 Suppl):87. PubMed ID: 16312317
    [No Abstract]   [Full Text] [Related]  

  • 39. Therapeutic strategies involving antimicrobial treatment of disseminated bacterial infection in small animals.
    Garvey MS; Aucoin DP
    J Am Vet Med Assoc; 1984 Nov; 185(10):1185-9. PubMed ID: 6392253
    [No Abstract]   [Full Text] [Related]  

  • 40. [Carbapenem antibiotic ertapenem in the treatment of extrahospital intraabdominal infections].
    Zaĭtsev AA
    Khirurgiia (Mosk); 2003; (4):51-4. PubMed ID: 12744138
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.